Historique de carrière de Sarah DiSalvatore
Anciens postes connus de Sarah DiSalvatore
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Directeur Technique/Scientifique/R&D | 01/11/2021 | 01/04/2023 |
| ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
- Bourse
- Insiders
- Sarah DiSalvatore
- Expérience
